Influence of high-dose antithrombin concentrate therapy on the release of cellular proteinases, cytokines, and soluble adhesion molecules in acute inflammation.
Jochum
M
M
Abteilung fur Klinische Chemie and Klinische, Biochemie in der Chirurgischen Klinik und Poliklinik, Munchen, Germany.
D000208:Acute Disease; D000328:Adult; D000990:Antithrombin III / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D001778:Blood Coagulation Disorders / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control; D015815:Cell Adhesion Molecules / Q000502:physiology*; D016207:Cytokines / Q000378:metabolism*; D010450:Endopeptidases / Q000378:metabolism*; D006801:Humans; D007249:Inflammation / Q000188:drug therapy* / Q000503:physiopathology; D008875:Middle Aged; D009102:Multiple Organ Failure / Q000097:blood / Q000150:complications / Q000503:physiopathology; D009104:Multiple Trauma / Q000097:blood / Q000150:complications / Q000503:physiopathology; D009369:Neoplasms / Q000097:blood / Q000150:complications / Q000503:physiopathology / Q000601:surgery; D010865:Pilot Projects; D012636:Secretory Rate / Q000187:drug effects; D018805:Sepsis / Q000097:blood / Q000150:complications / Q000401:mortality / Q000503:physiopathology
D015815:Cell Adhesion Molecules; D016207:Cytokines; D000990:Antithrombin III; D010450:Endopeptidases